Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA.

Trends Neurosci. 2008 May;31(5):234-42. doi: 10.1016/j.tins.2008.02.005. Epub 2008 Apr 7. Review.

2.

Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J.

Science. 2008 Apr 25;320(5875):539-43. doi: 10.1126/science.1155174. Epub 2008 Mar 27.

3.

Evidence of altered cortical and amygdala activation during social decision-making in schizophrenia.

Baas D, Aleman A, Vink M, Ramsey NF, de Haan EHF, Kahn RS.

Neuroimage. 2008 Apr 1;40(2):719-727. doi: 10.1016/j.neuroimage.2007.12.039. Epub 2008 Jan 5.

PMID:
18261933
4.

DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia.

Szeszko PR, Hodgkinson CA, Robinson DG, Derosse P, Bilder RM, Lencz T, Burdick KE, Napolitano B, Betensky JD, Kane JM, Goldman D, Malhotra AK.

Biol Psychol. 2008 Sep;79(1):103-10. Epub 2007 Nov 1.

5.

Orbitofrontal volume deficit in schizophrenia and thought disorder.

Nakamura M, Nestor PG, Levitt JJ, Cohen AS, Kawashima T, Shenton ME, McCarley RW.

Brain. 2008 Jan;131(Pt 1):180-95. Epub 2007 Dec 3.

6.
7.

Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.

Kargieman L, Santana N, Mengod G, Celada P, Artigas F.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14843-8. Epub 2007 Sep 4.

8.

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.

Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD.

Nat Med. 2007 Sep;13(9):1102-7. Epub 2007 Sep 2. Erratum in: Nat Med. 2007 Oct;13(10):1264.

PMID:
17767166
9.

Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.

Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A.

Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14501-6. Epub 2007 Aug 3.

10.
11.
12.

Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders.

Sevy S, Burdick KE, Visweswaraiah H, Abdelmessih S, Lukin M, Yechiam E, Bechara A.

Schizophr Res. 2007 May;92(1-3):74-84. Epub 2007 Mar 26.

13.

Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction.

Waltz JA, Frank MJ, Robinson BM, Gold JM.

Biol Psychiatry. 2007 Oct 1;62(7):756-64. Epub 2007 Feb 14.

14.

Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology.

Lacerda AL, Hardan AY, Yorbik O, Vemulapalli M, Prasad KM, Keshavan MS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):510-6. Epub 2007 Jan 18.

PMID:
17239513
15.

Prefrontal cortex and insight in schizophrenia: a volumetric MRI study.

Sapara A, Cooke M, Fannon D, Francis A, Buchanan RW, Anilkumar AP, Barkataki I, Aasen I, Kuipers E, Kumari V.

Schizophr Res. 2007 Jan;89(1-3):22-34. Epub 2006 Nov 13.

PMID:
17097853
16.

Dysfunctional prefrontal regional specialization and compensation in schizophrenia.

Tan HY, Sust S, Buckholtz JW, Mattay VS, Meyer-Lindenberg A, Egan MF, Weinberger DR, Callicott JH.

Am J Psychiatry. 2006 Nov;163(11):1969-77.

PMID:
17074949
17.

Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine.

Homayoun H, Moghaddam B.

Biol Psychiatry. 2007 Mar 1;61(5):679-87. Epub 2006 Oct 13.

18.
19.

Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.

Toro CT, Hallak JE, Dunham JS, Deakin JF.

Neurosci Lett. 2006 Sep 1;404(3):276-81. Epub 2006 Jul 13.

PMID:
16842914
20.

A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions.

Ishizuka K, Paek M, Kamiya A, Sawa A.

Biol Psychiatry. 2006 Jun 15;59(12):1189-97. Review.

PMID:
16797264

Supplemental Content

Support Center